Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Center for Hemoglobin Research in Minorities2041 Georgia Avenue
Washington, DC, United States
The Center for Hemoglobin Reseach in Minorities was founded in 2012 and primarily aims to advance the study of hemoglobinopatheis, iron metabolism, and oxygen sensing.
With an emphasis on specific impacts on the minority community, CHaRM executes its investigative mission by:
-Educating and training minority students and fellows.
-Expanding and enhancing the research advances made by the Howard University Research Scientist Program in clinical and molecular aspects of sickle cell disease, iron metabolism, and oxygen sensing.
-Enhancing and facilitating existing collaborations within and outside of Howard University and share existing resources.
FDA Approves Hydroxyurea Tablets for Pediatric Patients With Sickle Cell AnemiaThe US Food and Drug Administration (FDA...
Emmaus, a leader in sickle cell disease treatment, signs agreement with McKesson to expand distribution network for ...Emmaus Life Sciences, Inc., anno...
Griffin P. Rodgers, MD, MACPDr. Griffin Rodgers, Director of the Nat...
Nadia Ewing, MDNadia Ewing, M.D., is a clinical profess...
Blood transfusion for preventing primary and secondary stroke in people with sickle cell diseaseBackground:Sickle cell disease is one of...
Orphan Drug Designation Granted for CSL Behring’s Investigational Plasma-Derived Hemopexin Therapy for Sickle ...Global biotherapeutics leader CSL Behrin...
Early occurrence of red blood cell alloimmunization in patients with sickle cell diseaseRed blood cell (RBC) alloimmunization is...